Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitors
Sanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination
Hui Huang, Sanath K Meegalla, James C Lanter, et al.
Journal of Medicinal Chemistry
|
January 12, 2011
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents
Raymond J Patch, Lily L Searle, Alexander J Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2016
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors
Sanath K Meegalla, Hui Huang, Carl R Illig, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
Carl R Illig, Jinsheng Chen, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors
Kenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2003
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)
Charles L Cywin, Bao-Ping Zhao, Daniel W McNeil, et al.
Journal of Medicinal Chemistry
|
April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)
William H Parsons, Raul R Calvo, Wing Cheung, et al.
Journal of Medicinal Chemistry
|
December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists
Daniel J Parks, William H Parsons, Raymond W Colburn, et al.
Journal of Medicinal Chemistry
|
November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)
Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitors
Sanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination
Hui Huang, Sanath K Meegalla, James C Lanter, et al.
Journal of Medicinal Chemistry
|
January 12, 2011
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents
Raymond J Patch, Lily L Searle, Alexander J Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2016
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors
Sanath K Meegalla, Hui Huang, Carl R Illig, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
Carl R Illig, Jinsheng Chen, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors
Kenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2003
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)
Charles L Cywin, Bao-Ping Zhao, Daniel W McNeil, et al.
Journal of Medicinal Chemistry
|
April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)
William H Parsons, Raul R Calvo, Wing Cheung, et al.
Journal of Medicinal Chemistry
|
December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists
Daniel J Parks, William H Parsons, Raymond W Colburn, et al.
Journal of Medicinal Chemistry
|
November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)
Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Page
of 8